FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023358654> ?p ?o ?g. }

• W2023358654 endingPage "1344" @default.
• W2023358654 startingPage "1339" @default.
• W2023358654 abstract "1 The role of α2-adrenoceptor (AR) subtypes in the modulation of acute nociception, motor behaviour and body temperature, has been investigated by determining the activity of the α2AR selective agonist dexmedetomidine (Dex) in mice devoid of individual α2AR subtypes through either a point (α2A) or null (α2B/α2C) mutation (‘knock-out’). 2 In a rodent model of acute thermal nociception, the mouse tail immersion test, Dex, in wild type (WT) control animals, produced a dose-dependent increase in the threshold for tail withdrawal from a 52°C water bath with mean ED50 values of 99.9±14.5 (α2A), 94.6±17.8 (α2B) and 116.0±17.1 (α2C) μg kg−1, i.p. 3 In comparison to the WT controls, Dex (100–1000 μg kg−1, i.p.), was completely ineffective as an antinociceptive agent in the tail immersion test in the α2AAR D79N mutant animals. Conversely, in the α2BAR and α2CAR knock-outs, Dex produced a dose-dependent antinociceptive effect that was not significantly different from that observed in WT controls, with ED50 values of 85.9±15.0 (P>0.05 vs WT control) and 226.0±62.7 (P>0.05 vs WT control) μg kg−1 i.p., respectively. 4 Dex (10–300 μg kg−1, i.p.) produced a dose-dependent reduction in spontaneous locomotor activity in the α2A, α2B and α2CAR WT control animals with ED50 values of 30.1±9.0, 23.5±7.1 and 32.3±4.6 μg kg−1, i.p., respectively. Again, Dex (100–1000 μg kg−1, i.p.) was ineffective at modulating motor behaviour in the α2AAR D79N mutants. In the α2BAR and α2CAR knock-out mice, Dex produced a dose-dependent reduction in spontaneous locomotor activity with ED50 values of 29.1±6.4 (P>0.05 vs WT control) and 57.5±11.3 (P>0.05 vs WT control) μg kg−1, respectively. 5 Dex was also found to produce a dose-dependent reduction in body temperature in the α2A, α2B and α2CAR WT control mice with ED50 values of 60.6±11.0, 16.2±2.5 and 47.2±9.1 μg kg−1, i.p., respectively. In the α2AAR D79N mutants, Dex had no effect on body temperature at a dose (100 μg kg−1, i.p.) that produced a significant reduction (−6.2±0.5°C; P<0.01 vs vehicle) in temperature in WT controls. However, higher doses of Dex (300 and 1000 μg kg−1, i.p) produced a small, but statistically significant decrease in temperature corresponding to −1.7±0.4°C and −2.4±0.3°C (both P<0.01 vs vehicle), respectively. In the α2BAR and α2CAR knock-out mice, Dex produced a dose-dependent reduction in body temperature with ED50 values of 28.4±4.8 (P>0.05 vs WT control) and 54.1±8.0 (P>0.05 vs WT control) μg kg−1, respectively. 6 In conclusion, the data are consistent with the α2AAR being the predominant subtype involved in the mediation of the antinociceptive, sedative and hypothermic actions of Dex. This profile would appear to indicate that an α2AAR subtype selective analgesic will have a narrow therapeutic window, particularly following systemic administration." @default.
• W2023358654 created "2016-06-24" @default.
• W2023358654 creator A5015773502 @default.
• W2023358654 creator A5019032811 @default.
• W2023358654 creator A5021593027 @default.
• W2023358654 creator A5025539645 @default.
• W2023358654 creator A5054678312 @default.
• W2023358654 creator A5063940122 @default.
• W2023358654 creator A5072070682 @default.
• W2023358654 creator A5078255099 @default.
• W2023358654 creator A5091026355 @default.
• W2023358654 date "1997-12-01" @default.
• W2023358654 modified "2023-09-30" @default.
• W2023358654 title "Assessment of the role of α₂-adrenoceptor subtypes in the antinociceptive, sedative and hypothermic action of dexmedetomidine in transgenic mice" @default.
• W2023358654 cites W1592358009 @default.
• W2023358654 cites W1966132930 @default.
• W2023358654 cites W1977966461 @default.
• W2023358654 cites W1983165959 @default.
• W2023358654 cites W1989738897 @default.
• W2023358654 cites W1998514242 @default.
• W2023358654 cites W2003996864 @default.
• W2023358654 cites W2005135333 @default.
• W2023358654 cites W2006913937 @default.
• W2023358654 cites W2008411223 @default.
• W2023358654 cites W2009133356 @default.
• W2023358654 cites W2009374031 @default.
• W2023358654 cites W2009717522 @default.
• W2023358654 cites W2013314380 @default.
• W2023358654 cites W2014668182 @default.
• W2023358654 cites W2018452659 @default.
• W2023358654 cites W2028180285 @default.
• W2023358654 cites W2032871856 @default.
• W2023358654 cites W2033479223 @default.
• W2023358654 cites W2056720873 @default.
• W2023358654 cites W2057249572 @default.
• W2023358654 cites W2063940371 @default.
• W2023358654 cites W2072246563 @default.
• W2023358654 cites W2080202671 @default.
• W2023358654 cites W2084235775 @default.
• W2023358654 cites W2085913537 @default.
• W2023358654 cites W2089177274 @default.
• W2023358654 cites W2093538708 @default.
• W2023358654 cites W2116881916 @default.
• W2023358654 cites W2121433470 @default.
• W2023358654 cites W2127797084 @default.
• W2023358654 cites W2152658482 @default.
• W2023358654 cites W2152953741 @default.
• W2023358654 cites W2474292363 @default.
• W2023358654 cites W4240143568 @default.
• W2023358654 cites W4313371117 @default.
• W2023358654 doi "https://doi.org/10.1038/sj.bjp.0701520" @default.
• W2023358654 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1565079" @default.
• W2023358654 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9421280" @default.
• W2023358654 hasPublicationYear "1997" @default.
• W2023358654 type Work @default.
• W2023358654 sameAs 2023358654 @default.
• W2023358654 citedByCount "251" @default.
• W2023358654 countsByYear W20233586542012 @default.
• W2023358654 countsByYear W20233586542013 @default.
• W2023358654 countsByYear W20233586542014 @default.
• W2023358654 countsByYear W20233586542015 @default.
• W2023358654 countsByYear W20233586542016 @default.
• W2023358654 countsByYear W20233586542017 @default.
• W2023358654 countsByYear W20233586542018 @default.
• W2023358654 countsByYear W20233586542019 @default.
• W2023358654 countsByYear W20233586542020 @default.
• W2023358654 countsByYear W20233586542021 @default.
• W2023358654 countsByYear W20233586542022 @default.
• W2023358654 countsByYear W20233586542023 @default.
• W2023358654 crossrefType "journal-article" @default.
• W2023358654 hasAuthorship W2023358654A5015773502 @default.
• W2023358654 hasAuthorship W2023358654A5019032811 @default.
• W2023358654 hasAuthorship W2023358654A5021593027 @default.
• W2023358654 hasAuthorship W2023358654A5025539645 @default.
• W2023358654 hasAuthorship W2023358654A5054678312 @default.
• W2023358654 hasAuthorship W2023358654A5063940122 @default.
• W2023358654 hasAuthorship W2023358654A5072070682 @default.
• W2023358654 hasAuthorship W2023358654A5078255099 @default.
• W2023358654 hasAuthorship W2023358654A5091026355 @default.
• W2023358654 hasBestOaLocation W20233586541 @default.
• W2023358654 hasConcept C126322002 @default.
• W2023358654 hasConcept C134018914 @default.
• W2023358654 hasConcept C15490471 @default.
• W2023358654 hasConcept C170493617 @default.
• W2023358654 hasConcept C185592680 @default.
• W2023358654 hasConcept C197711040 @default.
• W2023358654 hasConcept C2776814716 @default.
• W2023358654 hasConcept C2777602617 @default.
• W2023358654 hasConcept C2778938600 @default.
• W2023358654 hasConcept C2781302539 @default.
• W2023358654 hasConcept C42533223 @default.
• W2023358654 hasConcept C71924100 @default.
• W2023358654 hasConcept C79410662 @default.
• W2023358654 hasConcept C86803240 @default.
• W2023358654 hasConcept C98274493 @default.
• W2023358654 hasConceptScore W2023358654C126322002 @default.
• W2023358654 hasConceptScore W2023358654C134018914 @default.
• W2023358654 hasConceptScore W2023358654C15490471 @default.

• next